Showing 1,621 - 1,640 results of 100,585 for search '(( 50 points decrease ) OR ( 5 ((((teer decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.31s Refine Results
  1. 1621
  2. 1622
  3. 1623
  4. 1624
  5. 1625
  6. 1626

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…To mitigate the systemic adverse effects of tofacitinib, 5-ASA–PABA–MAC and 5-ASA–PABA–diamine colon-specific delivery systems were constructed, and tofacitinib azo prodrugs <b>9</b> and <b>20a–20g</b> were synthesized accordingly. …”
  7. 1627

    Impaired Functions of Macrophage from Cystic Fibrosis Patients: CD11b, TLR-5 Decrease and sCD14, Inflammatory Cytokines Increase by Karin Simonin-Le Jeune (464354)

    Published 2013
    “…Furthermore expression of CD11b and TLR-5 were sorely decreased on CF macrophages. Beside, no difference was observed for mCD14, CD16, CD64, TLR-4 and TLR1/TLR-2 expressions. …”
  8. 1628

    Decreased copper content and activity/expression of SOD1 in circulating erythrocytes from <i>ms/−</i> mice. by Małgorzata Lenartowicz (150659)

    Published 2014
    “…<p>(<b>A</b>) Decreased copper content in erythrocytes of <i>ms/−</i> mice. …”
  9. 1629
  10. 1630
  11. 1631
  12. 1632
  13. 1633

    Targeting <i>A20</i> decreases glioma stem cell survival. by Anita B. Hjelmeland (104655)

    Published 2010
    “…<p>(A) Annexin V staining demonstrates increased apoptosis with <i>A20</i> targeting in glioma stem cells isolated from a D317 glioma xenograft or a T3359 patient specimen passaged short term in immunocompromised mice. …”
  14. 1634
  15. 1635
  16. 1636
  17. 1637
  18. 1638

    Data_Sheet_1_Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection.doc by Yanhua Wu (141984)

    Published 2023
    “…The change of both absolute and relative risks for hospitalization was more evident (RR = 0.47, 95%CI: 0.42–0.53;RD% =10.61, 95%CI: 8.64–12.59) and a significant increase was observed for the absolute differences in death in the elderly (RD% = 5.60, 95CI%: 4.65–6.55); the change of the absolute differences in the risk of hospitalization and death were most markedly observed in the patients with booster vaccination (RD%<sub>hospitalization</sub> = 8.60, 95CI%: 5.95–11.24; RD%<sub>death</sub> = 3.70, 95CI%: 0.34–7.06).…”
  19. 1639
  20. 1640